Latest IDL Diagnostics News & Updates
See the latest news and media coverage for IDL Diagnostics. We track all announcements, press releases, and industry mentions in real time, all in one place.
Swedish diagnostics company for oncological and bacterial diseases
idldiagnostics.com- Headquarters
- Bromma, Sweden
- Founded year
- 2000
- Company type
- Public company
- Number of employees
- 25–50
Last updated
Latest news about IDL Diagnostics
In short: IDL Diagnostics announced that CEO Anders Hultman will step down after five years, coinciding with a period of record revenue and expansion.
Company announcements
-
IDL Diagnostics calls annual general meeting
The meeting is held on 28 May 2026 in Bromma. The nomination committee proposes re-election of board members and authorisation for emissions.
-
IDL Diagnostics announces CEO Anders Hultman stepping down
The Board praises his leadership in growth and mergers. He will stay during transition while recruiting a new CEO.
-
IDL Diagnostics presents Q4 2025 interim report
CEO Anders Hultman and CFO Ellen Dittberner present results on February 26, 2026.
-
IDL Diagnostics releases Q4 2025 Year-end Report
Highlights include record quarterly revenue, 16% urology sales growth, and first TPS CLIA order from Japan for China.
Media coverage
-
CEO of IDL Diagnostics to leave
IDL Diagnostics has agreed with Anders Hultman that he will leave his role as CEO, after five years in the position.
-
IDL Diagnostics AB (publ) Interim Report January 1st to December 31st, 2025 | MarketScreener
A word from the CEO”IDL Diagnostics ends 2025 with a strong quarter, achieving the highest revenue for a single quarter in the company’s history. During...
-
IDL Diagnostics changes accounting principles to IFRS starting from...
IDL Diagnostics announces that the company’s board has decided to change the accounting principles from the Swedish K3 regulations to the International Financial Reporting Standards...
-
IDL Diagnostics AB: First commercial order from Japanese partner secured for the Chinese market
IDL Diagnostics has secured its first commercial order for TPS CLIA from its Japanese partner, a leading global Japanese IVD company, for deployment within the...
Track IDL Diagnostics and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
IDL Diagnostics competitors & trending companies
Browse news for competitors to IDL Diagnostics and other trending companies.
Biovica
Pit
Davis AI
Qutwo
DigiPowerX
Penguin Solutions
Sterling Infrastructure
KIOXIA Corporation
Subquadratic
Tibber
IREN
A24
Hitachi Energy
Ouster
Ormat Technologies
Fabrinet
AOI
WidePoint
Filtronic
Mirum Pharmaceuticals
Capstone Green Energy
AXT
POET Technologies
PurpleFire
Profitable Media
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove